相似文献
1
Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.
Endocrinol Metab Clin North Am. 2013 Sep;42(3):489-501. doi: 10.1016/j.ecl.2013.05.009.
2
Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.
J Neurol Sci. 2010 Jan 15;288(1-2):112-6. doi: 10.1016/j.jns.2009.09.022.
3
[Dementia and diabetes: casual or causal relationship?].
Med Clin (Barc). 2015 Feb 20;144(4):176-80. doi: 10.1016/j.medcli.2014.01.026. Epub 2014 Mar 13.
4
Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis.
Diabetes Obes Metab. 2016 Feb;18(2):135-41. doi: 10.1111/dom.12587. Epub 2015 Dec 8.
5
Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
J Am Med Dir Assoc. 2015 Apr;16(4):349.e7-12. doi: 10.1016/j.jamda.2014.12.014. Epub 2015 Feb 7.
6
Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
Discov Med. 2013 Dec;16(90):277-86.
7
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways.
CNS Drugs. 2019 Feb;33(2):143-160. doi: 10.1007/s40263-018-0601-x.
8
Cognitive Dysfunction in Older Adults with Type 2 Diabetes: Links, Risks, and Clinical Implications.
Clin Geriatr Med. 2020 Aug;36(3):407-417. doi: 10.1016/j.cger.2020.04.002. Epub 2020 Apr 17.
9
The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence.
South Med J. 2010 Jan;103(1):58-65. doi: 10.1097/SMJ.0b013e3181c35776.
10
[Preventive strategy for cognitive decline in elderly with diabetes mellitus].
Nihon Rinsho. 2014 Apr;72(4):692-6.
引用本文的文献
1
Prevalence and pattern of cognitive dysfunction in young adults and middle-aged patients with type-2 diabetes.
J Family Med Prim Care. 2025 Jun;14(6):2527-2537. doi: 10.4103/jfmpc.jfmpc_1900_24. Epub 2025 Jun 30.
2
A Comparative Study of Nanoconjugates of a Synthetic and a Natural Drug Against T2DM-Induced Cognitive Dysfunction.
J Neuroimmune Pharmacol. 2025 Feb 1;20(1):11. doi: 10.1007/s11481-025-10170-0.
3
Prevalence of Cognitive Decline in Type 2 Diabetes Mellitus Patients: A Real-World Cross-Sectional Study in Mysuru, India.
J Pers Med. 2023 Mar 15;13(3):524. doi: 10.3390/jpm13030524.
4
Sleeve gastrectomy attenuated diabetes-related cognitive decline in diabetic rats.
Front Endocrinol (Lausanne). 2022 Nov 3;13:1015819. doi: 10.3389/fendo.2022.1015819. eCollection 2022.
5
Pathophysiological Association Between Diabetes Mellitus and Alzheimer's Disease.
Cureus. 2022 Sep 13;14(9):e29120. doi: 10.7759/cureus.29120. eCollection 2022 Sep.
6
Altered Gray Matter Volume, Functional Connectivity, and Degree Centrality in Early-Onset Type 2 Diabetes Mellitus.
Front Neurol. 2021 Sep 9;12:697349. doi: 10.3389/fneur.2021.697349. eCollection 2021.
7
Berberine elevates mitochondrial membrane potential and decreases reactive oxygen species by inhibiting the Rho/ROCK pathway in rats with diabetic encephalopathy.
Mol Pain. 2021 Jan-Dec;17:1744806921996101. doi: 10.1177/1744806921996101.
8
Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes.
Diabetes Care. 2021 Mar;44(3):655-662. doi: 10.2337/dc20-2031. Epub 2021 Jan 19.
9
Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review.
Alzheimers Dement. 2021 Jan;17(1):41-48. doi: 10.1002/alz.12175. Epub 2020 Oct 8.
10
Berberine ameliorates rats model of combined Alzheimer's disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress.
3 Biotech. 2020 Aug;10(8):359. doi: 10.1007/s13205-020-02354-7. Epub 2020 Jul 29.
本文引用的文献
1
Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.
J Alzheimers Dis. 2013;35(4):789-97. doi: 10.3233/JAD-122308.
2
2013 Alzheimer's disease facts and figures.
Alzheimers Dement. 2013 Mar;9(2):208-45. doi: 10.1016/j.jalz.2013.02.003.
3
The PPARγ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model.
Cancer Chemother Pharmacol. 2013 Apr;71(4):929-36. doi: 10.1007/s00280-013-2084-2. Epub 2013 Jan 29.
4
Insulin and Alzheimer's disease: untangling the web.
J Alzheimers Dis. 2013;33 Suppl 1:S263-75. doi: 10.3233/JAD-2012-129042.
5
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.
J Cereb Blood Flow Metab. 2012 Dec;32(12):2146-52. doi: 10.1038/jcbfm.2012.118. Epub 2012 Aug 29.
6
Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats.
Life Sci. 2012 Oct 5;91(11-12):409-414. doi: 10.1016/j.lfs.2012.08.017. Epub 2012 Aug 20.
7
Insulin in the brain: there and back again.
Pharmacol Ther. 2012 Oct;136(1):82-93. doi: 10.1016/j.pharmthera.2012.07.006. Epub 2012 Jul 17.
8
Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study.
Neuroepidemiology. 2012;38(4):237-44. doi: 10.1159/000337428. Epub 2012 May 5.
9
Insulin and sex interactions in older adults with mild cognitive impairment.
J Alzheimers Dis. 2012;31(2):401-10. doi: 10.3233/JAD-2012-120202.
10
Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease.
J Alzheimers Dis. 2012;30(4):943-61. doi: 10.3233/JAD-2012-111661.
Zotero 插件